45
Participants
Start Date
August 31, 2002
Primary Completion Date
May 31, 2005
Study Completion Date
May 31, 2005
N-acetylcysteine
Medication packages were prepared and dispensed by pharmacy and included three premixed and prepackaged minibags containing either 5 g of NAC or placebo in 100 cc D5W (pre-CT dose) or 2.5 g of NAC or placebo in 50 cc D5W (post-CT doses).
D5W Placebo
Medication packages were prepared and dispensed by pharmacy and included three premixed and prepackaged minibags containing either 5 g of NAC or placebo (D5W) in 100 cc D5W (pre-CT dose) or 2.5 g NAC or placebo in 50 cc D5W (post-CT doses).
London Health Sciences Centre - Victoria Hospital, London
London Health Sciences Centre - University Hospital Campus, London
Martin, Claudio M., M.D.
INDIV
Fran Priestap
UNKNOWN
Unity Health Toronto
OTHER